| ₹ crore | Q2 FY27 | Q2 FY26 | Change |
|---|---|---|---|
| EBITDA | 1,216 | 1,045 | +16.4% |
| Profit before tax | 1,247 | 1,077 | +15.8% |
| Net profit | 946 | 820 | +15.5% |
| EPS | ₹18.95 | ₹16.49 | +14.9% |
| Tap a line for its trend | Q2 FY27Sep 2026 | Q1 FY27Jun 2026 | Q4 FY26Mar 2026 | Q3 FY26Dec 2025 | Q2 FY26Sep 2025 | Q1 FY26Jun 2025 | Q4 FY25Mar 2025 |
|---|
| 31.0 | 5.8 | 31.6 | 15.8 | 32.1 | 4.5 | 0.3 | |
Expenses | |||||||
| 1,216 | 530 | 687 | 854 | 1,045 | 989 | 668 | |
| 1,216 | 530 | 687 | 854 | 1,045 | 989 | 668 | |
Profit | |||||||
| 1,247 | 536 | 718 | 870 | 1,077 | 994 | 668 | |
| 946 | 403 | 547 | 659 | 820 | 747 | 510 | |
Per share | |||||||
| ₹18.95 | ₹8.08 | ₹10.97 | ₹13.25 | ₹16.49 | ₹15.06 | ₹10.29 | |
Revenue detail — as filed | |||||||
| 7,844 | 6,814 | 6,619 | 6,610 | 6,583 | 6,083 | 5,851 | |
| 1,161 | 858 | 797 | 909 | 899 | 943 | 625 | |
Expense detail — as filed | |||||||
| 458 | 426 | 425 | 464 | 409 | 431 | 393 | |
| 1,269 | 1,250 | 1,188 | 1,343 | 1,013 | 941 | 1,026 | |
| 1,269 | 1,250 | 1,188 | 1,343 | 1,013 | 941 | 1,026 | |
| 0.0 | 0.0 | 175 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 0.0 | 0.0 | 3,925 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 34.7 | −13.8 | 65.6 | 11.8 | −4.9 | −14.4 | 7.3 | |
| 15.3 | −36.0 | 49.0 | 0.0 | −31.8 | −28.5 | −2.5 | |
| −1.2 | 0.9 | −0.3 | −3.6 | 4.5 | 0.1 | −1.2 | |
Profit build-up — alternate / pre-Ind-AS tags | |||||||
| 1,247 | 536 | 718 | 870 | 1,077 | 994 | 668 | |
| 1,247 | 536 | 718 | 870 | 1,077 | 994 | 668 | |
| 301 | 133 | 172 | 211 | 258 | 247 | 159 | |
| 946 | 403 | 547 | 659 | 820 | 747 | 510 | |
| 9,860 | 8,914 | 8,860 | 8,314 | 7,978 | 7,159 | 6,759 | |
Per share — as-filed variants | |||||||
| ₹18.95 | ₹8.08 | ₹10.97 | ₹13.25 | ₹16.49 | ₹15.06 | ₹10.29 | |
| ₹18.95 | ₹8.08 | ₹10.97 | ₹13.25 | ₹16.49 | ₹15.06 | ₹10.29 | |
Appropriations & transfers | |||||||
| 873 | 234 | 546 | 571 | 753 | 654 | 416 | |
| 17,467 | 16,460 | 16,308 | 15,691 | 15,263 | 14,327 | 13,807 | |
| 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | |
| 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | |
Insurance — revenue account (Policyholders') | |||||||
| 6,652 | 5,950 | 5,791 | 5,685 | 5,652 | 5,136 | 5,226 | |
| 7,702 | 8,860 | 8,074 | 7,433 | 7,059 | 8,053 | 6,904 | |
| 6,214 | 6,604 | 6,487 | 5,963 | 5,313 | 5,611 | 5,481 | |
| 863 | 785 | 786 | 792 | 743 | 738 | 666 | |
| 20.6 | 21.2 | 16.8 | 15.5 | 22.4 | 14.0 | 11.0 | |
| 4,652 | 3,512 | 3,925 | 3,428 | 3,278 | 2,911 | 3,510 | |
| 4,839 | 4,545 | 4,100 | 3,904 | 4,074 | 3,750 | 3,743 | |
| 187 | 1,033 | 175 | 476 | 796 | 840 | 233 | |
Insurance — Shareholders' account | |||||||
| 1,282 | 522 | 784 | 882 | 1,072 | 979 | 676 | |
| 407 | 280 | 238 | 310 | 319 | 317 | 200 | |
| 873 | 234 | 546 | 571 | 753 | 654 | 416 | |
| 0.1 | 0.0 | −0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
Insurance — result & transfers | |||||||
| −318 | −630 | −282 | −354 | −178 | −293 | −210 | |
| 873 | 234 | 546 | 571 | 753 | 654 | 416 | |
| 1.3 | 7.8 | 0.3 | 0.0 | 0.9 | 8.4 | 59.3 | |
Insurance — IRDAI ratios (as filed, not percentages) | |||||||
| 2.75× | 2.71× | 2.67× | 2.69× | 2.73× | 2.70× | 2.69× | |
| ₹0.03 | ₹0.03 | ₹0.03 | ₹0.03 | ₹0.03 | ₹0.03 | ₹0.03 | |
| ₹1.07 | ₹1.07 | ₹1.01 | ₹1.04 | ₹1.05 | ₹1.03 | ₹1.03 | |
| ₹0.73 | ₹0.76 | ₹0.71 | ₹0.69 | ₹0.72 | ₹0.73 | ₹0.72 | |
| ₹0.81 | ₹0.75 | ₹0.80 | ₹0.80 | ₹0.75 | ₹0.70 | ₹0.79 | |
| ₹0.36 | ₹0.29 | ₹0.32 | ₹0.35 | ₹0.32 | ₹0.28 | ₹0.33 | |
Regulatory disclosures — filed alongside, not part of the P&L | |||||||
| ₹0.00 | −₹1.00 | ₹1.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | |
| ₹0.00 | ₹1.00 | ₹1.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | |
| ₹0.00 | ₹2.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | |
| 1,503 | — | 2,136 | — | 1,946 | — | 1,957 | |
From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.
In ₹ Crore except Per Share 3 Months Ending | Q4 FY25 31/03/2025 | Q1 FY26 30/06/2025 | Q2 FY26 30/09/2025 | Q3 FY26 31/12/2025 | Q4 FY26 31/03/2026 | Q1 FY27 30/06/2026 | Q2 FY27 30/09/2026 | |
|---|---|---|---|---|---|---|---|---|
| Other Income | 0.3 | 4.5 | 32.1 | 15.8 | 31.6 | 5.8 | 31.0 | |
| Expenses | ||||||||
| EBITDA | 667.9 | 989.2 | 1,045.2 | 853.9 | 686.7 | 529.9 | 1,216.4 | |
| EBIT | 667.9 | 989.2 | 1,045.2 | 853.9 | 686.7 | 529.9 | 1,216.4 | |
| Profit | ||||||||
| Pretax Income | 668.2 | 993.7 | 1,077.3 | 869.8 | 718.2 | 535.7 | 1,247.4 | |
| Net Income | 509.6 | 747.1 | 819.5 | 658.8 | 546.6 | 403.2 | 946.4 | |
| Per Share | ||||||||
| Basic EPS | 10.29 | 15.06 | 16.49 | 13.25 | 10.97 | 8.08 | 18.95 | |
| Revenue Detail — as filed | ||||||||
| + Operating Income | 5,851.2 | 6,083.4 | 6,582.7 | 6,610.2 | 6,618.8 | 6,813.7 | 7,843.7 | |
| + Income from Investments (net) | 625.3 | 942.7 | 898.9 | 909.0 | 796.7 | 857.9 | 1,160.8 | |
| Expense Detail — as filed | ||||||||
| + Employee Remuneration & Welfare | 393.3 | 430.9 | 409.3 | 463.6 | 424.6 | 426.1 | 457.7 | |
| + Commission (net) | 1,026.4 | 940.8 | 1,012.8 | 1,343.1 | 1,187.6 | 1,250.2 | 1,268.6 | |
| + Commission & Brokerage (net) | 1,026.4 | 940.8 | 1,012.8 | 1,343.1 | 1,187.6 | 1,250.2 | 1,268.6 | |
| + Provision — Diminution in Investments | 0.0 | 0.0 | 0.0 | 0.0 | 175.1 | 0.0 | 0.0 | |
| + Provision — Doubtful Debts & Write-offs | 0.0 | 0.0 | 0.0 | 0.0 | 3,924.7 | 0.0 | 0.0 | |
| + Non-operating Expense | 7.3 | -14.4 | -4.9 | 11.8 | 65.6 | -13.8 | 34.7 | |
| + Non-operating Provision — Diminution in Investments | -2.5 | -28.5 | -31.8 | 0.0 | 49.0 | -36.0 | 15.3 | |
| + Non-operating Provision — Doubtful Debts | -1.2 | 0.1 | 4.5 | -3.6 | -0.3 | 0.9 | -1.2 | |
| Profit Build-up — Alternate / Pre-Ind-AS Tags | ||||||||
| Profit before Extraordinary Items | 668.2 | 993.7 | 1,077.3 | 869.8 | 718.2 | 535.7 | 1,247.4 | |
| Profit / (Loss) before Tax — alt tag | 668.2 | 993.7 | 1,077.3 | 869.8 | 718.2 | 535.7 | 1,247.4 | |
| + Provision for Tax | 158.6 | 246.6 | 257.7 | 211.0 | 171.6 | 132.5 | 301.0 | |
| Profit / (Loss) after Tax | 509.6 | 747.1 | 819.5 | 658.8 | 546.6 | 403.2 | 946.4 | |
| Profit Carried to Balance Sheet | 6,759.1 | 7,158.8 | 7,978.3 | 8,313.7 | 8,860.2 | 8,914.1 | 9,860.5 | |
| Per Share — as-filed variants | ||||||||
| Basic & Diluted EPS before Extraordinary (not annualised) | 10.29 | 15.06 | 16.49 | 13.25 | 10.97 | 8.08 | 18.95 | |
| Basic & Diluted EPS after Extraordinary (not annualised) | 10.29 | 15.06 | 16.49 | 13.25 | 10.97 | 8.08 | 18.95 | |
| Appropriations & Transfers | ||||||||
| + Transfer to Profit & Loss Account | 415.9 | 654.1 | 752.7 | 571.1 | 545.9 | 233.8 | 873.5 | |
| Reserves & Surplus excl. Revaluation Reserve | 13,807.4 | 14,327.2 | 15,263.3 | 15,691.1 | 16,308.4 | 16,460.0 | 17,466.7 | |
| + Interim Dividend | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | |
| + Final Dividend | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | |
| Insurance — Revenue Account (Policyholders') | ||||||||
| Premium Earned | 5,225.6 | 5,136.1 | 5,651.7 | 5,685.3 | 5,790.5 | 5,950.0 | 6,651.9 | |
| + Gross Premiums Written | 6,903.9 | 8,052.6 | 7,058.9 | 7,433.0 | 8,073.7 | 8,860.3 | 7,702.1 | |
| + Net Premium Written | 5,481.0 | 5,610.5 | 5,313.0 | 5,963.5 | 6,487.4 | 6,603.7 | 6,213.7 | |
| + Operating Expenses — Insurance Business | 665.7 | 738.4 | 742.9 | 791.8 | 785.5 | 785.2 | 862.8 | |
| + Non-operating Expenses — Non-insurance | 11.0 | 14.0 | 22.4 | 15.5 | 16.8 | 21.2 | 20.6 | |
| + Claims Paid | 3,510.3 | 2,910.5 | 3,278.2 | 3,427.8 | 3,924.7 | 3,511.6 | 4,652.1 | |
| + Incurred Claims | 3,743.2 | 3,750.1 | 4,074.4 | 3,904.2 | 4,099.8 | 4,544.5 | 4,838.8 | |
| + Change in Outstanding Claims | 232.9 | 839.6 | 796.2 | 476.4 | 175.1 | 1,032.9 | 186.7 | |
| Insurance — Shareholders' Account | ||||||||
| + Income — Shareholders' Account | 675.5 | 979.3 | 1,072.3 | 881.6 | 783.8 | 521.9 | 1,282.1 | |
| + Shareholders' Investment Income | 200.3 | 316.7 | 318.8 | 310.4 | 237.6 | 280.3 | 407.4 | |
| + Transfer from Policyholders' Fund | 415.9 | 654.1 | 752.7 | 571.1 | 545.9 | 233.8 | 873.5 | |
| With Unrealised Gains | 0.0 | 0.0 | 0.0 | 0.0 | -0.0 | 0.0 | 0.1 | |
| Without Unrealised Gains | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Insurance — Result & Transfers | ||||||||
| Underwriting Profit / (Loss) | -209.7 | -293.1 | -178.4 | -353.8 | -282.4 | -629.9 | -318.4 | |
| Operating Profit / (Loss) | 415.9 | 654.1 | 752.7 | 571.1 | 545.9 | 233.8 | 873.5 | |
| + Other Income — Shareholders' Account | 59.3 | 8.4 | 0.9 | 0.0 | 0.3 | 7.8 | 1.3 | |
| Insurance — IRDAI Ratios (as filed, not percentages) | ||||||||
| Solvency Ratio (x, one scale) | 2.69 | 2.70 | 2.73 | 2.69 | 2.67 | 2.71 | 2.75 | |
| Solvency Ratio (as filed) | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | |
| Combined Ratio | 1.03 | 1.03 | 1.05 | 1.04 | 1.01 | 1.07 | 1.07 | |
| Incurred Claim Ratio | 0.72 | 0.73 | 0.72 | 0.69 | 0.71 | 0.76 | 0.73 | |
| Net Retention Ratio | 0.79 | 0.70 | 0.75 | 0.80 | 0.80 | 0.75 | 0.81 | |
| Expenses of Management Ratio | 0.33 | 0.28 | 0.32 | 0.35 | 0.32 | 0.29 | 0.36 | |
| Regulatory Disclosures — filed alongside, not part of the P&L | ||||||||
| Investor Complaints — During the Period | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | -1.00 | 0.00 | |
| Investor Complaints — Received | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 1.00 | 0.00 | |
| Investor Complaints — Disposed | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.00 | 0.00 | |
| Related-party Transactions — During the Period | 1,957.0 | — | 1,946.0 | — | 2,135.9 | — | 1,503.3 | |
| Other Filed Concepts — mapped but not yet placed in the schedule | ||||||||
| Operating Expenses | 5,435.3 | 5,429.2 | 5,830.0 | 6,039.1 | 6,072.9 | 6,579.9 | 6,970.3 | |
| Other Operating Expenses | 272.3 | 307.5 | 333.6 | 328.2 | 361.0 | 359.1 | 405.1 | |
Filed with NSE on Wednesday, 14 October 2026 at 7:20 pm IST
ICICI Lombard General Insurance (NSE: ICICIGI) reported its Q2 FY27 results (July–September 2026) on Wednesday, 14 October 2026 at 7:20 pm IST. Consolidated net profit was ₹946 crore, up 15.5% from ₹820 crore in Q2 FY26 and up 134.7% from ₹403 crore in Q1 FY27.
Consolidated net profit was ₹946 crore, up 15.5% from ₹820 crore in Q2 FY26 and up 134.7% from ₹403 crore in Q1 FY27.
Consolidated net profit for the first half of FY27 (April–September 2026) was ₹1,350 crore, down 13.9% from ₹1,567 crore in the same months a year earlier.
Net profit by quarter: ₹659 crore in Q3 FY26, ₹547 crore in Q4 FY26, ₹403 crore in Q1 FY27 and ₹946 crore in Q2 FY27. That is ₹2,555 crore over the four quarters.
Against Q2 FY26, net profit was up 15.5% at ₹946 crore. Against Q1 FY27, net profit was up 134.7%.
Basic earnings per share were ₹18.95, against ₹16.49 in Q2 FY26.
Consolidated net profit was ₹2,772 crore in FY26 (April 2025–March 2026), up 10.5% from ₹2,508 crore in FY25.
On Wednesday, 14 October 2026 at 7:20 pm IST, in its results filing to the stock exchanges. A year earlier it reported Q2 FY26 on 14 October 2025.
Yes. The board declared an interim dividend of ₹7 per share on 14 October 2026. The record date is 23 October 2026.
Q3 FY27 covers October–December 2026. Listed companies must publish quarterly results within 45 days of the quarter's end (SEBI listing rules, Regulation 33), so the results are due by 14 February 2027. The company tells the exchanges the date of the board meeting at least two working days before it.
From ICICI Lombard General Insurance's own consolidated results filings to NSE, in ₹ crore as filed (Q2 FY27 on 14 October 2026). Growth compares the same consolidated figures a year and a quarter earlier.
Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.